DalsnaFinance › IPOs › Cullinan Therapeutics Inc › IPO
Cullinan Therapeutics, Inc. completed its initial public offering on NASDAQ on January 8, 2021, pricing at $21.00 a share.
| Ticker | CGEM |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 8, 2021 |
| Offering price | $21.00 |
| Shares offered | 11,900,000 |
| Total raised | $250M |
Cullinan Therapeutics, Inc. sold 11,900,000 shares at $21.00 each on NASDAQ. Multiplied out, that is $249.9 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $250 million total recorded for the deal.
Cullinan Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Cullinan Therapeutics, Inc.. This page is general information, not investment advice.